[1]
Sfriso, P. et al. 2008. The risk/benefit profile of biologic drugs in real-world rheumatology practice. From ANTARES to MonitorNet. Reumatismo. 60, 2 (Jun. 2008), 77–84. DOI:https://doi.org/10.4081/reumatismo.2008.77.